Maniakas, A., Gillenwater, A. M., Cognetti, D., Mifsud, M. J., Ashraf, N., Civantos, F. F., Danesi, H., Veresh, B., Chen, S. E., Dong, H., Larracas, C., Arnold, S. M. (2025). A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6122